In terms of effector T cells, in the active immune response state, SCFAs promote effector T-cell generation and, at the same time, can increase the cytotoxicity of CD8+ T cells and the ability to generate IL-17, whereas in the physiological state, SCFA promotes the body’s immune tolerance to effector T cells through the increase in the generation of IL-10, which, in turn, can have an inhibitory effect on chronic inflammatory responses in hypertension (138). This evidence concerns the gene IL10 and hypertensive disorder.